Indefinite Delivery Contract 75D30120D07979

Award Date 4/23/20
Last Date to Order 4/22/21
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Corgenix Medical Corporation, a foreign-owned, small disadvantaged business manufacturer of goods. The $23,650,000 contract is for "SURGE SEROLOGY TESTING" services, with a period of performance from April 23, 2020 to April 22, 2021. As an IDC, this contract allows the CDC to issue task orders for serology testing services as needed. The contract does not appear to have any...
The Indefinite Delivery Contract is a multiple award issued by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. It has a potential value of $23,750,000 and was awarded on April 23, 2020 to the University of Washington School of Medicine for SURGE SEROLOGY TESTING. No set-aside was used. Orders may be placed through April 22, 2021. The purpose of the contract is to provide surge serology testing in support of the Centers for Disease Control and...
The federal contract IDV award is an Indefinite Delivery Contract (IDC) with a ceiling value of $102,000,000 awarded by the Centers for Disease Control and Prevention (CDC) to Battelle Memorial Institute, a large non-profit research and development organization. The contract is part of the Immunization Consulting and Research ARM (ICRA) IDIQ, a multiple-award IDC vehicle that provides for other functions beyond the core ICRA services. The scope of the IDC includes a broad range of scientific,...
The Centers for Disease Control and Prevention awarded an indefinite delivery contract to Laboratory Corporation of America Holdings to provide surge serology testing services in support of COVID-19 response efforts. The multiple award contract has a potential value of $23.75 million and was awarded on May 7, 2020 to aid the agency through April 22, 2021. Two firm fixed price delivery orders have been issued against the contract to date. Laboratory Corporation will perform testing from its...
This Indefinite Delivery Contract is a multiple award IDIQ awarded by the Centers for Disease Control and Prevention (CDC) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The $118 million contract, with an ultimate completion date of September 5, 2029, is for "Test Surge and Data Sharing" services. Under this IDIQ, Ginkgo Bioworks is expected to provide testing and data sharing capabilities to support the CDC's public health monitoring and emergency...
The Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a $118 million ceiling value to Aegis Sciences Corporation, a for-profit forensic toxicology and healthcare laboratory, to provide "TEST SURGE AND DATA SHARING" support services. Under this IDIQ, the CDC has issued two firm fixed price and time and materials task orders to Aegis. The first is a $2,427,648.50 firm fixed price task order with a period of...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Bioreference Health LLC for surge serology testing in support of COVID-19 response efforts. The potential value of the contract vehicle is $23.75 million. Under the contract, Bioreference Health will perform testing services out of its laboratory in Elmwood Park, New Jersey. A $1.85 million firm fixed price delivery order was issued to Bioreference Health to conduct testing from July 30,...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Quest Diagnostics Incorporated for surge serology testing services. The contract established a potential value of $23.75 million for Quest Diagnostics to provide COVID-19 antibody testing from its Secaucus, New Jersey laboratory in support of the CDC's pandemic response. A $14 million firm fixed price delivery order to Quest Diagnostics expanded the scope of work. Under the delivery order,...
The Indefinite Delivery Contract (IDC) awarded by the Assisted Acquisition Services FEDSIM division of the General Services Administration (GSA) to Battelle Memorial Institute (Battelle) aims to procure a broad range of platform-related services. The $3.5 million multiple-award contract has a period of performance lasting until November 14, 2031. Battelle, a non-profit research and development organization, will provide the government with scientific, engineering, testing, manufacturing, and...
This federal contract IDV award is a multiple award Indefinite Delivery, Indefinite Quantity (IDIQ) contract titled "TEST SURGE AND DATA SHARING MULTIPLE AWARD IDIQ" with a total ceiling value of $118,000,000.00. It was awarded by the Centers for Disease Control and Prevention (CDC) to the prime contractor, Arup Laboratories Inc., doing business as Associated Regional And University Pathologists, a not-for-profit clinical and anatomic pathology reference laboratory. The contract aims...

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide serology surge testing services. The contract has a ceiling value of $23,750,000 and a period of performance from April 2020 to April 2021.

As a multiple award IDC, this vehicle provides the CDC with flexible access to Battelle's scientific and technical capabilities in areas such as biological, chemical, and engineering research, testing, and development. Battelle frequently serves as both a prime and subcontractor on federal contracts, leveraging partnerships to deliver a wide range of goods and services to agencies across domains like defense, homeland security, health, energy, and transportation. This specific IDC is intended to support the CDC's serology testing surge requirements, though Battelle likely has the capacity to provide the government with additional research, engineering, and laboratory services under this or other IDIQ contract vehicles.

Generated 6/28/24, 9:12 AM